News

Create it REAL takes part in fighting Covid-19 and gets support from the Innovation Fund

Create it REAL

14. april, 2020

Create it REAL is participating in fighting the coronavirus. By offering their online slicer as a freemium, it makes it easier for people holding a 3D printer to print different equipment that can help hospitals in need. Their software makes it more than twice as fast to print in 3D with the same quality as have been seen previously. They want to push this new service around the world and hope that as many as possible will take part in the fight and help their communities.

Create it REAL has figured out their way to help fighting Covid-19. Create it REAL offers software that can be used for 3D printers to print faster and better quality. Therefore, it can help boosting the productivity of 3D printer enthusiasts, also called 'makers'. Create is REAL is focusing on their technology and know-how to improve the software, and leave the printing to those makers. Thus, Create it REAL provides their online slicer service for free for makers during the time of this crisis, only if they do it in order to help for instance the hospitals in their community. This can be done by printing facemasks, protection shields, and respirator adaptors (which can allow for the use of 1 respirator to up to 8 patients).

“We have the technology to speed up the print time, this means higher production output for hundreds of thousands of makers all around the world, and an impact on millions of people. It is a question of life or death, so it was a no brainer for our team to make the technology freely available to maximize impact against covid-19.” says Jeremie Pierre Gay, Create it REAL CEO.

It is a question of life or death, so it was a no brainer for our team to make the technology freely available to maximize impact against covid-19."

Create it REAL has just received an Innobooster from the Innovation Fund that will help them pursue this new strategy and therefore, be able to reach as many people around the world as possible. Actually, they have managed to build up a new business model, which allows them to both offer their service for free for anyone who wants to take part in the fight, as well as at the same time exploiting from gaining new customers that will stay afterwards. Therefore, the hope is, to first of all, make an impact in this time of crisis, but at the same time being able to grow their customer segment.

Vaekstfonden has invested in, and been following Create it REAL on their journey.

“As professional investors, we are focused on growing the company, but we understand that impact investment can create growth. We have trust into Create it REAL's ability to support this health crisis short term while creating a return on growth long term” says Ole Kring Investment Director in Vaekstfonden’s VF Venture team.

Seneste nyheder

Ung gruppe af kolleger
24-06-2020
News

Danish tech company completes first investment round: Will open the “black box” of sales call

The Danish tech company Capturi completes its first investment round of a total €11.6M Euro. Capturi has developed a technology that can identify and categorize the good sales arguments in customer conversations, thus opening up a new world of knowledge about conversation techniques that for many companies has so far been a black box. Now the company is ready to go in the market for customers, and together with Vaekstfonden, employees and a number of private investors have additionally joined the investment.

Vækstfonden
23-06-2020
NEWS

DOES YOUR START-UP NEED A HELPING HAND?

Today we’re launching ‘A Helping Hand’ together with a group of Danish venture investors and industry experts. What is the aim? To help Nordic start-ups adapt to the new normal.

OBI Medical
28-05-2020
News

The global leader in pharmaceutical products and diagnostic tests, Roche, acquires the Danish company OBI Medical ApS

The Swiss company, Roche, has acquired the Danish company OBI Medical in March 2020. Roche is a global leader in pharmaceutical products and diagnostic tests, therefore they saw a potential in the Danish company focusing on developing disruptive blood gas testing technology. OBI Medical has developed a pioneering v-TAC technology that allows for an easier and simpler way to test patients’ blood gas. Today, it is called the Roche v-TAC digital solution and can not only be used to help testing blood gas, but also be a tool to help efficiency in the times of COVID-19 to simplify the monitoring of patients.